412 related articles for article (PubMed ID: 26462884)
1. Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency.
Farah BL; Landau DJ; Sinha RA; Brooks ED; Wu Y; Fung SYS; Tanaka T; Hirayama M; Bay BH; Koeberl DD; Yen PM
J Hepatol; 2016 Feb; 64(2):370-379. PubMed ID: 26462884
[TBL] [Abstract][Full Text] [Related]
2. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.
Waskowicz LR; Zhou J; Landau DJ; Brooks ED; Lim A; Yavarow ZA; Kudo T; Zhang H; Wu Y; Grant S; Young SP; Huat BB; Yen PM; Koeberl DD
Hum Mol Genet; 2019 Jan; 28(1):143-154. PubMed ID: 30256948
[TBL] [Abstract][Full Text] [Related]
3. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
Zhou J; Waskowicz LR; Lim A; Liao XH; Lian B; Masamune H; Refetoff S; Tran B; Koeberl DD; Yen PM
Thyroid; 2019 Aug; 29(8):1158-1167. PubMed ID: 31337282
[No Abstract] [Full Text] [Related]
4. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
[TBL] [Abstract][Full Text] [Related]
5. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context.
Monteillet L; Gjorgjieva M; Silva M; Verzieux V; Imikirene L; Duchampt A; Guillou H; Mithieux G; Rajas F
Mol Metab; 2018 Oct; 16():100-115. PubMed ID: 30100243
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia.
Cho JH; Kim GY; Pan CJ; Anduaga J; Choi EJ; Mansfield BC; Chou JY
PLoS Genet; 2017 May; 13(5):e1006819. PubMed ID: 28558013
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
Yavarow ZA; Kang HR; Waskowicz LR; Bay BH; Young SP; Yen PM; Koeberl DD
Hum Mol Genet; 2020 Jan; 29(2):286-294. PubMed ID: 31816064
[TBL] [Abstract][Full Text] [Related]
8. Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa).
Farah BL; Sinha RA; Wu Y; Singh BK; Lim A; Hirayama M; Landau DJ; Bay BH; Koeberl DD; Yen PM
Sci Rep; 2017 Mar; 7():44408. PubMed ID: 28317891
[TBL] [Abstract][Full Text] [Related]
9. The absence of hepatic glucose-6 phosphatase/ChREBP couple is incompatible with survival in mice.
Rajas F; Dentin R; Cannella Miliano A; Silva M; Raffin M; Levavasseur F; Gautier-Stein A; Postic C; Mithieux G
Mol Metab; 2021 Jan; 43():101108. PubMed ID: 33137488
[TBL] [Abstract][Full Text] [Related]
10. The signaling pathways implicated in impairment of hepatic autophagy in glycogen storage disease type Ia.
Gautam S; Zhang L; Arnaoutova I; Lee C; Mansfield BC; Chou JY
Hum Mol Genet; 2020 Mar; 29(5):834-844. PubMed ID: 31961433
[TBL] [Abstract][Full Text] [Related]
11. Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.
Hijmans BS; Boss A; van Dijk TH; Soty M; Wolters H; Mutel E; Groen AK; Derks TGJ; Mithieux G; Heerschap A; Reijngoud DJ; Rajas F; Oosterveer MH
Hepatology; 2017 Dec; 66(6):2042-2054. PubMed ID: 28727166
[TBL] [Abstract][Full Text] [Related]
12. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK/mTOR/ULK1-dependent pathway in nonalcoholic fatty liver disease.
Zhang D; Zhang Y; Wang Z; Lei L
Phytother Res; 2023 Mar; 37(3):781-797. PubMed ID: 36479746
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
15. Renal endoplasmic reticulum stress is coupled to impaired autophagy in a mouse model of GSD Ia.
Farah BL; Landau DJ; Wu Y; Sinha RA; Loh A; Bay BH; Koeberl DD; Yen PM
Mol Genet Metab; 2017 Nov; 122(3):95-98. PubMed ID: 28888852
[TBL] [Abstract][Full Text] [Related]
16. 1,2-Dichloroethane impairs glucose and lipid homeostasis in the livers of NIH Swiss mice.
Wang T; Xu D; Fan Q; Rong W; Zheng J; Gao C; Li G; Zeng N; Guo T; Zeng L; Wang F; Xiao C; Cai L; Tang S; Deng X; Yin X; Huang M; Lu F; Hu Q; Chen W; Huang Z; Wang Q
Toxicology; 2017 Apr; 380():38-49. PubMed ID: 28189721
[TBL] [Abstract][Full Text] [Related]
17. Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.
Cho JH; Kim GY; Mansfield BC; Chou JY
Biochem Biophys Res Commun; 2018 Apr; 498(4):925-931. PubMed ID: 29545180
[TBL] [Abstract][Full Text] [Related]
18. Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia.
Cho JH; Lee YM; Bae SH; Chou JY
Biochem Biophys Res Commun; 2020 Jan; 522(1):1-7. PubMed ID: 31735334
[TBL] [Abstract][Full Text] [Related]
19. The role of kidney in the inter-organ coordination of endogenous glucose production during fasting.
Kaneko K; Soty M; Zitoun C; Duchampt A; Silva M; Philippe E; Gautier-Stein A; Rajas F; Mithieux G
Mol Metab; 2018 Oct; 16():203-212. PubMed ID: 29960865
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A-I improves hepatic autophagy through the AMPK pathway.
Rao X; Wang Y
Biochimie; 2019 Oct; 165():210-218. PubMed ID: 31401190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
